(Q37083271)

18 August 2017

1 reference

title

The value of incomplete mouse models of Alzheimer's disease (English)

1 reference

18 August 2017

0 references

4

Mathias Jucker

1 reference

18 August 2017

Rebecca Radde

1

1 reference

18 August 2017

Cecilia Duma

series ordinal

2

1 reference

18 August 2017

Michel Goedert

series ordinal

3

1 reference

18 August 2017

publication date

1 March 2008

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

18 August 2017

published in

1 reference

18 August 2017

volume

35 Suppl 1

1 reference

18 August 2017

page(s)

S70-4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-007-0704-y

18 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0704-Y

Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-007-0704-Y

Setback for an Alzheimer's disease vaccine: lessons learned.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-007-0704-Y

Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography

21 January 2018

1 reference

12 December 2020

Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models

1 reference

12 December 2020

A century of Alzheimer's disease

1 reference

12 December 2020

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

12 December 2020

APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.

1 reference

12 December 2020

Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease

1 reference

12 December 2020

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

1 reference

12 December 2020

Cerebral hemorrhage after passive anti-Abeta immunotherapy.

1 reference

12 December 2020

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

12 December 2020

Abeta40 inhibits amyloid deposition in vivo.

1 reference

12 December 2020

Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.

1 reference

12 December 2020

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice

1 reference

12 December 2020

Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches.

1 reference

12 December 2020

Prion strain discrimination using luminescent conjugated polymers

1 reference

12 December 2020

Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease

1 reference

12 December 2020

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

1 reference

12 December 2020

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

1 reference

12 December 2020

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

1 reference

12 December 2020

Cystatin C modulates cerebral beta-amyloidosis

1 reference

12 December 2020

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

1 reference

12 December 2020

Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology

1 reference

12 December 2020

Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

1 reference

12 December 2020

FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction

1 reference

12 December 2020

Tau filament formation in transgenic mice expressing P301L tau.

1 reference

12 December 2020

Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.

1 reference

12 December 2020

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

12 December 2020

Neuron loss in APP transgenic mice

1 reference

12 December 2020

Presenilin: running with scissors in the membrane

1 reference

12 December 2020

Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.

1 reference

12 December 2020

Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein

1 reference

12 December 2020

Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice.

1 reference

12 December 2020

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

1 reference

12 December 2020

Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice

1 reference

12 December 2020

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

1 reference

12 December 2020

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

1 reference

12 December 2020

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

12 December 2020

Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease

1 reference

12 December 2020

Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes

1 reference

12 December 2020

10.1007/S00259-007-0704-Y

Identifiers

DOI

1 reference

18 August 2017

1 reference